Landiolol, an ultra-short-acting beta(1)-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study) - Sakamoto, A; Kitakaze, M; Takamoto, S (Circulation journal: official journal of the Japanese Circulation Society, 2012)
et al.